OKYO: OKYO Pharma Limited Stock

SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)

Valuation
Market Cap ($M) 35.53
Enterprise Value ($M) 34.54
Book Value ($M) -7.23
Book Value / Share -0.21
Price / Book -4.92
NCAV ($M) -7.23
NCAV / Share -0.21
Price / NCAV -4.92

Profitability (mra)
Return on Invested Capital (ROIC) n/a
Return on Assets (ROA) n/a
Return on Equity (ROE) n/a

Liquidity (mrq)
Quick Ratio 0.28
Current Ratio 0.28

Balance Sheet (mrq) ($M)
Current Assets 2.83
Assets 2.83
Liabilities 10.05
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)
Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-02-04 25,275 72,392 34.91
2025-02-03 15,649 51,323 30.49
2025-01-31 15,369 79,388 19.36
2025-01-30 91,515 278,385 32.87

(click for more detail)

Similar Companies
OCEA – Ocean Biomedical, Inc. OCGN – Ocugen, Inc.
OCX – OncoCyte Corporation ONCO – Onconetix, Inc.
ONCY – Oncolytics Biotech Inc.


Financial data and stock pages provided by
Fintel.io